9 trials changed in the last 30 days: 0 stopped, 4 with notable changes, 5 with minor changes only.
Primary and study completion pushed from Aug 31, 2026 to May 31, 2027
Brown UniversityPhase 2 NCT05540067 Registry history of NCT05540067 on ClinicalTrials.gov (opens the registry)
Updated
Primary completion pushed from Jun 2026 to Jun 2027
Also in this update: Enrollment closed, study ongoing; Study completion pushed from Jun 2026 to Aug 2027
Brown UniversityNot applicable NCT05736614 Registry history of NCT05736614 on ClinicalTrials.gov (opens the registry)
Updated
Recruitment opened
Brown UniversityPhase 1 NCT07818564 Registry history of NCT07818564 on ClinicalTrials.gov (opens the registry)
Updated
Recruitment opened
Also in this update: Start date pushed from Oct 1, 2026 to Oct 8, 2026
Brown UniversityNot applicable NCT07854756 Registry history of NCT07854756 on ClinicalTrials.gov (opens the registry)
Updated
Enrollment closed, study ongoing
Also in this update: Primary completion date changed from estimate of May 15, 2026 to Jun 16, 2026; Study completion pushed from May 15, 2026 to Nov 2026
Brown UniversityNot applicable NCT04430257 Registry history of NCT04430257 on ClinicalTrials.gov (opens the registry)
Updated
Trial completed
Brown UniversityNot applicable NCT04994873 Registry history of NCT04994873 on ClinicalTrials.gov (opens the registry)
Updated
Trial completed
Also in this update: Final enrollment: 226 participants (planned 600); Primary completion date changed from estimate of Apr 15, 2026 to Sep 13, 2026
Brown UniversityNot applicable NCT04546971 Registry history of NCT04546971 on ClinicalTrials.gov (opens the registry)
Updated
Primary completion pushed from Mar 31, 2027 to Aug 31, 2027
Also in this update: Study completion pushed from Mar 31, 2027 to Dec 31, 2027
Brown UniversityPhase 2 NCT05389930 Registry history of NCT05389930 on ClinicalTrials.gov (opens the registry)
Updated
Study completion pushed from Jan 2026 to Oct 20, 2026
Brown UniversityNot applicable NCT06445010 Registry history of NCT06445010 on ClinicalTrials.gov (opens the registry)
Updated
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-02 | NCT07854756 Supporting Health Through Alcohol Reduction and Relationship Enhancement Together | Recruiting |
| Phase 1 | 2 | |
| Phase 1/2 | 3 | |
| Phase 2 | 13 | |
| Phase 3 | 2 | |
| Phase 4 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT05901766 | Effects of Maternal Multiple Micronutrient Supplementation During Lactation on Child… | Iodine Deficiency | Not Yet Recruiting | 2026-09-09 |
| Phase 3 | ||||
| NCT05285917 | Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa | Sickle Cell Anemia in Children | Recruiting | 2026-08-20 |
| NCT06998069 | Head and Neck Cancer Study Project in the Geriatric Population | Head and Neck Neoplasms | Recruiting | 2026-08-20 |
| Phase 2 | ||||
| NCT05389930 | Cannabis' Impact on Alcohol Consumption | Alcohol Drinking | Recruiting | 2026-10-05 |
| NCT04792502 | Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and… | Follicular Lymphoma | Recruiting | 2026-08-20 |
| NCT04933903 | BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab… | Non Small Cell Lung Cancer | Recruiting | 2026-08-20 |
| NCT06555133 | Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC | Colorectal Carcinoma Metastatic in the Liver | Recruiting | 2026-08-20 |
| NCT07118618 | Probenecid Administration for Alcohol Craving and Consumption | Alcohol Use Disorder (AUD) | Recruiting | 2026-03-17 |
| NCT06974604 | Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM | Breast Neoplasms | Recruiting | 2025-10-24 |
| NCT06969950 | Evaluating an Intervention for Physician Burnout | Physician Burnout | Recruiting | 2025-05-14 |
| NCT05540067 | Improving Mental Health Among the LGBTQ+ Community | Anxiety | Active, Not Recruiting | 2026-10-13 |
| NCT04135846 | Alpha-1 Blockade for Alcohol Use Disorder (AUD) | Alcohol Use Disorder (AUD) | Active, Not Recruiting | 2026-09-23 |
| NCT07502872 | TPG: Tafasitamab, Polatuzumab Vedotin, and Glofitamab as First-line Therapy for Diffuse… | Diffuse Large B Cell Lymphoma | Not Yet Recruiting | 2026-09-01 |
| NCT03355976 | BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas | Ovarian Cancer | Active, Not Recruiting | 2026-08-20 |
| NCT05480384 | Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free… | Esophageal Adenocarcinoma | Active, Not Recruiting | 2026-04-21 |
| NCT02656706 | Adjuvant Nivolumab & Low Dose Ipilimumab for Stage III & Resected Stage IV Melanoma | Melanoma | Active, Not Recruiting | 2026-04-13 |
| Phase 1/2 | ||||
| NCT05988632 | Intranasal Insulin for Treatment of Alcohol Use Disorder | Alcohol Use Disorder | Recruiting | 2026-09-30 |
| NCT07698613 | EGFR Targeted Photoimmunotherapy With ASP-1929 for Locally Advanced Pancreatic Cancer | Pancreatic Cancer Patients Diagnosed With Locally Advanced or Metastatic Pancreatic Cancer Not Amenable to Curative Surgical Resection | Not Yet Recruiting | 2026-07-13 |
| NCT04253262 | A Study of Copanlisib Combined With Rucaparib in Patients With Metastatic… | Metastatic Castration-resistant Prostate Cancer | Active, Not Recruiting | 2025-05-04 |
| Phase 1 | ||||
| NCT07818564 | Pilot Study on the Effects of Psilocybin on Belief Updating and Insight Formation | Phase I | Recruiting | 2026-10-08 |
| NCT07658196 | TLR9 Immunotherapy for Peritoneal Carcinomatosis | Malignant Ascites | Recruiting | 2026-10-01 |
| Not applicable | ||||
| NCT07854756 | Supporting Health Through Alcohol Reduction and Relationship Enhancement Together | Unhealthy Alcohol Use | Recruiting | 2026-10-05 |
| NCT06822569 | Teen Health Choices & Wellness | Health Behavior | Recruiting | 2026-09-29 |
| NCT07787026 | Assessing the Short-Term Effects of Multi-Fiber Supplementation on Gut Health | Mixed Fiber Supplementation for Healthy Adults | Recruiting | 2026-08-26 |
| NCT06099288 | Strong Families Start at Home/Familias Fuertes Comienzan en Casa | Metabolic Syndrome, Protection Against | Recruiting | 2026-08-06 |
Depression (3) · Anxiety (2) · Colorectal Cancer (2) · Lung Cancer (2) · Non-Hodgkin Lymphoma (2) · Non-Small Cell Lung Cancer (NSCLC) (2) · Breast Cancer (1) · Diabetes (1) · DLBCL (1) · Esophageal Cancer (1)